Screening for Access to Firearms by Pediatric Trainees in High-Risk Patients

Caitlin Naureckas Li(Lurie Children's Hospital), Michael R. Flaherty(Harvard University), Chana A. Sacks(Harvard University), Peter T. Masiakos(Massachusetts General Hospital), Kyle A. McGregor(York University)

Academic Pediatrics

March 7, 2019

10.1016/j.acap.2019.03.002

Cited by 63

Related Papers

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

|New England Journal of Medicine|2020|1.4k

Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.

|PubMed|1999|122

Paradigm Shifts in Heart-Failure Therapy — A Timeline

|New England Journal of Medicine|2014|114

Müllerian Inhibiting Substance Inhibits Ovarian Cell Growth through an Rb-independent Mechanism

|Journal of Biological Chemistry|2000|86

Oral Anticoagulant Utilization in the United States and United Kingdom

|Journal of General Internal Medicine|2020|79